Has Naum Shaparin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $69,548 in general payments to Naum Shaparin, MD across 167 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Naum Shaparin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Naum Shaparin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Naum Shaparin, MD

Pain Medicine · Bronx, NYNPI 1164615878

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by GRT US Holding, Inc. at 57.5% of the total. Reporting peaked in 2019 at $50,424 and has fallen 93.1% since, to $3,502 in 2025. Among pain medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$69,548in general payments, 2019–2025

Across 167 payments — averaging $416.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GRT US Holding, Inc.$40K
Acelrx Pharmaceuticals, Inc.$21K
BD$4K
Boston Scientific$2K
Medtronic$824
AbbVie$241
plus $2K from 19 others

$108,648in research payments, 2019–2025

Across 26 payments — averaging $4178.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Acelrx Pharmaceuticals, Inc.$39K
Heron Therapeutics, Inc.$33K
GRT US Holding, Inc.$29K
Averitas Pharma Inc.$8K

What the payments were for

Consulting fees$34,67550%
Speaking & faculty fees$4,5006%
Travel & lodging$23,55134%
Food & beverage$6,82210%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GRT US Holding, Inc.	41	$40,007
Acelrx Pharmaceuticals, Inc.	25	$20,513
BD	3	$4,050
Boston Scientific	23	$2,042
Medtronic(2 entities)	21	$824
AbbVie(2 entities)	8	$241
Mallinckrodt Enterprises LLC	2	$219
Avanos Medical	4	$197
Cumberland Pharmaceuticals, Inc.	7	$170
Vertex	4	$138
Stimwave Technologies Incorporated	4	$135
SPR Therapeutics, Inc	1	$128
Relievant Medsystems, Inc.	2	$126
Heron Therapeutics, Inc.	4	$122
Eagle Pharmaceuticals, Inc.	4	$122
Portola Pharmaceuticals, LLC	1	$118
Vertiflex, Inc.	2	$102
Abbott	1	$80
MML US, Inc.	1	$42
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$35
Palette Life Sciences, Inc.	1	$31
Saluda Medical Americas, Inc.	2	$29
Nevro Corp.	2	$28
Merck	1	$26
Flowonix Medical Incorporated	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Qutenza$39,113
DSUVIA$20,235
BD Intelliport$4,050
WaveWriter Alpha Prime 16$558
GENERAL PAIN MANAGEMENT$388
GENERAL - THERAPIES$286
OFIRMEV$219
INTELLIS ADAPTIVESTIM$173
Superion Indirect Decompression System$142
SPRINT PNS System$128
ON-Q* PUMP AND ACCESSORIES$123
ANDEXXA$118
Intracept$102

How this compares

$69,548 in reported general payments places this provider in the 95th percentile of 503 pain medicine providers in New York.

See all pain medicine providers in New York →

Medicare billing

Part B allowed, 2024

$2,278

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pain medicine in Bronx

Fred CohenBronx$141K
Valeriya KlatsBronx$71K
Gary SchwartzBrooklyn$756K
Amitabh GulatiNew York$614K
William CaldwellStony Brook$530K
Brian DurkinPort Jefferson$455K
David SpinnerNew York$391K
Grace FordeNew Hyde Park$355K
Romanth WaghmaraeHamburg$158K
Samuel BrownSouthold$147K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →